No abstract

Nine liquid disinfectants were tested for their ability to reduce infectivity of Cryptosporidium parvum oocysts in cell culture. A 4-min exposure to 6% hydrogen peroxide and a 13-min exposure to ammonium hydroxideamended windshield washer fluid reduced infectivity 1,000-fold. Other disinfectants tested (70% ethanol, 37% methanol, 6% sodium hypochlorite, 70% isopropanol, and three commercial disinfectants) did not reduce the infectivity after a 33-min exposure. The results indicate that hydrogen peroxide and windshield washer fluid or ammonium hydroxide disinfectant may be suitable laboratory disinfectants against C. parvum oocysts.

Cryptosporidium parvum oocysts were stored in 1-ml aliquots of filtered river water at -20, 4, 10, and 21-23 C in the dark. Oocysts were also added to filter-sterilized river water samples and stored at 21-23 C. The infectivity of oocysts stored under different conditions was assayed at weekly intervals through infection of human adenocarcinoma ileocecal (HCT-8) cell monolayers. Wells containing between 10 and 100 foci of infection were enumerated by immunofluorescent microscopy, and the number of infective oocysts was calculated. No infectious oocysts were detected after 1 wk at -20 C. The number of infective oocysts stored at 4 C decreased 5-fold, and the number of those stored at 10 C decreased 2.5-fold after 14 wk. The infectivity of oocysts stored in potassium dichromate (positive control) at 4 C decreased 2-fold over 14 wk. The number of infective oocysts in filter-sterilized and non-filter-sterilized river water stored at 21-23 C decreased by 3.3 and 2.6 log units, respectively, over 12 wk, and no foci of infection were detected at 14 wk. The results show that as temperature increased from 4 to 23 C, the duration of oocyst infectivity decreased.

Recent outbreaks of cryptosporidiosis from contaminated water supplies have led to a need for the detection of Cryptosporidium oocysts from various hosts and contaminating sources. The presence of nonpathogenic species or strains of Cryptosporidium is important for diagnostic purposes as there is a potential for false- positive detection of pathogenic parasites. The present review focuses on phenotypic differences and recent advances in genotypic analyses of the genus Cryptosporidium with an emphasis on detecting various isolates and identifying differences in Cryptosporidium parvum and other species in this genus. The information currently available demonstrates important patterns in DNA sequences of Cryptosporidium, and our understanding of macro- and microevolutionary patterns has increased in recent years. However, current knowledge of Cryptosporidium genetic diversity is far from complete, and the large amount of both phenotypic and genotypic data has led to problems in our understanding of the systematics of this genus.

The genetic variability of 10 Cryptosporidium parvum isolates of human and animal origin was investigated using amplified fragment length polymorphism (AFLP). Analysis of fluorescent dye-labeled amplified products was carried out using an ABI PRISMS 377 DNA sequencer and ABI PRISMS GeneScan software. One-hundred and twelve primer combinations were evaluated using a single C. parvum isolate. The patterns generated were highly reproducible. For subsequent study, a subset of 9 primer pairs that yielded 30-90 DNA fragments after the polymerase chain reaction, within the size range of 50-500 bp, was used to screen the 10 C. parvum isolates, including 7 bovine, 1 equine, and 2 of human origin. The animal isolates produced identical fingerprint patterns with every primer combination tested. Of the 2 human isolates tested, 1 of the isolates, passaged in calves, generated the same AFLP DNA banding patterns as the animal isolates, whereas the other isolate, obtained directly from human feces, produced unique patterns. Polymorphism, detected by comparison of the fingerprint patterns of the latter human isolate with the common pattern shared by all other isolates, ranged from 17 to 35% for the 9 primer pairs. The results show that AFLP is a useful method for differentiating C. parvum isolates into 2 distinct genotypes.

Escherichia coli JM109 (Gram-negative) and Bacillus subtilis (Gram-positive) were grown under hypobaric conditions for 19 days at 25 °C to study the effects of 33 and 67 kPa low pressures on selected physiological responses; growth, cytoplasmic membrane polarization (measure of cytoplasmic membrane fluidity) and total cellular fatty acids. In the first experiment, cytoplasmic membrane polarization in B. subtilis increased under both hypobaric conditions, indicating the membrane became more rigid or less fluid. This experiment was repeated and the effect of the hypobaric conditions was not evident as in the first experiment with B. subtilis. In addition, total cellular fatty acids analysis for B. subtilis showed that hypobaric conditions did not alter the ratio of saturated to unsaturated fatty acids. The cytoplasmic membrane remained in the same fluid state in hypobaric grown E. coli cell cultures as in the 101 kPa ambient control cells in both experiments. However, the saturated to unsaturated ratios were altered in E. coli under hypobaric conditions. It is important to note the ratios for E. coli were less than 1, while the ratios for Bacillus were in the 28–50 range. Growth of both species was also measured by colony forming units at the termination of the 19 day experiment. Both bacterial species were capable of growth under hypobaric conditions and no distinct trend emerged as to the effect of hypobaric pressure on bacterial growth and cytoplasmic membrane fluidity.

Exposure of Cryptosporidium parvum oocysts to solutions used for cellulose acetate membrane (CAM) dissolution filtration reduced their infectivity in HCT-8 cells. Ethanol (95% [vol/vol] and 70% [vol/vol]) aloneand short exposure times to acetone decreased infectivity. These findings contrast with similar experiments using excystation assays and infectivity in mice.Successful detection of Cryptosporidium parvum oocysts in water samples depends on efficient filtration methods to recover oocysts. Method 1623 from the U.S. Environmental Protection Agency involves filtering a 10-liter water sample using the Gelman Envirochek membrane capsule filter that traps oocysts. The filter is then shaken to recover the oocysts in an elution buffer (15,25). Other filtration methods, such as the use of polycarbonate membranes or polypropylene cartridge filters, have been described (13,(17)(18)(19). The purpose of these methods is to recover oocysts from raw or finished water samples. Suitable filtration methods should not render oocysts noninfective through chemical or mechanical treatments so infective oocysts in samples can be determined.An alternative filtration method involves capture of oocysts on a cellulose acetate membrane (CAM) that is dissolved in acetone following filtration and is subsequently centrifuged, rinsed in ethanol, and eluted in a buffer for final recovery (1). This method has an average rate of recovery up to 70.5%, making it more reliable than other methods (1, 2). When modified into a Millipore Glass Microanalysis system, the method resulted in higher oocyst recoveries, particularly when 1 liter of the elution buffer per 25 liters of low-turbidity water was used (10).The viability of C. parvum oocysts can be determined by vital dye staining, exposing oocysts to excystation solutions, and testing their infectivity by infecting mice. In recent years various cell culture methods have been developed whereby C. parvum oocysts or sporozoites are applied to cells grown in vitro (5,6,12,(20)(21)(22)24). As an alternative to the other assays, we used the HCT-8 cell line to study the effects of the various components of the CAM dissolution procedure on C. parvum infectivity.Oocysts of C. parvum (GCH1 isolate) were obtained from the AIDS Research and Reference Reagent Program, Division of AIDS, National Institute of Allergy and Infections Diseases, National Institutes of Health, through McKessonHBOC BioServices, Rockville, Md. For all experiments, oocysts were between 2 and 7 months old. The oocysts were stored in 2.5% (wt/vol) potassium dichromate at 4°C throughout the experimentation period.Oocyst suspensions were centrifuged for 3 min at 11,750 ϫ g in sterile 1.5-ml Eppendorf tubes, and pellets were resuspended in phosphate-buffered saline (PBS), pH 7.2. Approximately 10 6 control and experimental oocysts (determined by hemocytometer counts of stock solutions) were aliquoted into tubes.To simulate the CAM dissolution method, a procedure similar to that of Aldom and Chagla (1) was used. A 47-mmdiameter CAM with an...

Two phage display antibody libraries (Tomlinson I and J) were screened against the whole oocysts of Cryptosporidium parvum to select for scFv (single chain variable fragment) antibodies. Three scFv antibodies were selected that bound to C. parvum oocysts as determined by monoclonal phage ELISA. DNA sequencing revealed that clone A11 lacked the majority of its V (H) chain. Clone B10 had a stop codon in the first framework region of the V (H) chain. We changed this stop codon to Gly by site-directed mutagenesis, and designated the variant mutB10. Clone B9 had a complete scFv gene with no internal stop codons. These antibody genes were individually subcloned into the pET-20b expression vector for soluble scFv antibody production. C. parvum infectivity was determined by infection of HCT-8 tissue culture monolayers and quantified by the foci detection method. By incubating C. parvum oocysts with individual scFv antibodies for 1 h at 37 degrees C prior to infecting the HCT-8 cells with the oocyst-scFv mixture, the infectivity of C. parvum was reduced in a dose-dependent manner. At the highest soluble scFv concentration tested (4 nmol), the mean number of infectious foci was reduced by 82%, 73% and 94% for the A11, B9 and mutB10 scFv, respectively. This inhibition of oocyst infectivity was abolished when the scFvs were exposed to boiling water. The results showed that the 3 selected scFvs bound to C. parvum oocysts, and their ability to neutralize infectivity may have potential therapeutic potential against cryptosporidiosis.